Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection
Published: 08/03/2026
Sources:
- Food and Drug Administration
Relevant To:
- Ambulatory Surgical Centers,
- Urgent Care,
- Critical Access Hospitals,
- Hospitals,
- Ambulatory Care,
- Office-Based Surgery,
- Rural Health Clinics
The FDA is aware that Medline has issued a letter to affected customers recommending certain convenience kits be corrected prior to continued use by removing included Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injections.  Huons Co., Ltd. initiated a recall of Lidocaine Hydrochloride Injection and Bupivacaine HCL in Dextrose Injection following a recent FDA inspection of its manufacturing facility, which identified quality issues.
Affected Devices
- Medline Conven…